Dr. Maie Abdul-Rahman St John, MD

Dr. St John practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. St John's NPI, 1023029162, was assigned on August 11, 2006. Dr. St John graduated from Yale School of Medicine in 1999. Dr. St John holds California license A75058.

Dr. St John's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. St John's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. St John is also affiliated with The Johns Hopkins Hospital. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Dr. St John to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. St John practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. St John's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. St John is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. St John is licensed in California.

Dmand AI lists thyroid surgery among the conditions Dr. St John treats.

CMS data shows 373 Medicare services from Dr. St John across 9 procedure codes in 2024, for 191 Medicare patients. Medicare paid $80,697 for them.

CMS counts 191 Medicare patients who saw Dr. St John in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. St John's median patient age at 67, with 38% women.

In 2024, Dr. St John wrote 60 Medicare Part D claims for 36 patients. 97% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. St John for performance year 2024, reported as part of a group.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. St John, published from 2011 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Biomarkers, Tumor and Carcinoma, Squamous Cell. Dr. St John has published most often in Laryngoscope. Dr. St John's most frequent co-authors are Laith A. Mukdad, MD, Elliot Abemayor, MD and Steven M. Dubinett, MD.

CMS Open Payments shows 53 general payments to Dr. St John from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Ethicon Inc. paid the most, $21,911.

Dmand AI lists 8 awards for Dr. St John.

Dr. St John graduated from Yale School of Medicine in 1999. Dr. St John is a member of NHS, AACR, ACS, American Head & Neck Society and Triology Society.

Dr. St John is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.